Macaque models for AIDS vaccine development (Q41103089)

26 September 2017

1 reference

title

Macaque models for AIDS vaccine development (English)

1 reference

26 September 2017

0 references

Johnson RP

1

1 reference

26 September 2017

publication date

1 August 1996

1 reference

Current Opinion in Immunology

26 September 2017

published in

1 reference

26 September 2017

volume

8

1 reference

26 September 2017

issue

4

1 reference

26 September 2017

page(s)

554-560

1 reference

Isolation of T-cell tropic HTLV-III-like retrovirus from macaques

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Origins of simian immunodeficiency virus infection in macaques at the New England Regional Primate Research Center

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

High-titer immune responses elicited by recombinant vaccinia virus priming and particle boosting are ineffective in preventing virulent SIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Importance of the nef gene for maintenance of high virus loads and for development of AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Simian immunodeficiency virus DNA vaccine trial in macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Passive immunization of rhesus macaques against SIV infection and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Passive immunization of cynomolgus macaques with immune sera or a pool of neutralizing monoclonal antibodies failed to protect against challenge with SIVmac251.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Prolonged clinical latency and survival of macaques given a whole inactivated simian immunodeficiency virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

T cell receptor V beta repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian-human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV)

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Persistent infection with SIVmac chimeric virus having tat, rev, vpu, env and nef of HIV type 1 in macaque monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980046-X

7 January 2021

10.1016/S0952-7915(96)80046-X

Identifiers

DOI

1 reference

26 September 2017

1 reference